ArticlePloS one2025
Psychometric properties of the exercise self-efficacy scale in patients with chronic obstructive pulmonary disease.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study explores the psychometric properties of the Exercise Self-Efficacy (ESE) scale among individuals with Chronic Obstructive Pulmonary Disease (COPD). The secondary objective was to evaluate the relationship between self-efficacy, functional exercise capacity, health-related quality of life and psychological state in the same population.
methodsThis cross-sectional study was carried out in primary care centers in Spain. The sample was comprised of 156 people with COPD in whom anthropometric and clinical information was recorded. The ESE scale and other measures on functional exercise capacity, psychological state and health-related quality of life were administered. Psychometric properties were assessed through construct validity (EFA, exploratory factor analysis; CFA, confirmatory factor analysis), internal consistency, floor/ceiling effects and convergent validity. In this way, a quantitative, predictive and correlational research was carried out.
resultsThe EFA ruled out the structure of a single factor (Barletts's test p < 0.001, Kaiser-Meyer-Olkin 0.9). ACF suggested that the most appropriate adjustment model was the two-factor solution (comparative fit index = 0.967, Tucker-Lewis index = 0.961, root mean square approximation = 0.075, standardized root mean square residual = 0.058). Thus, ESE scale is best interpreting using 15 items distributed in 2 factors ("physical and occupational/environmental barriers" and "psychosocial barriers") than explained to 56.7% of the variance. With regard to reliability, Cronbach's alpha was = 0.92 and no floor or ceiling effects were observed. The scale showed a moderate/strong correlation with functional exercise capacity (r = 0.41), health-related quality of life (r= - 0.53) and psychological status (r= - 0.63).
conclusionsThe psychometric testing of the ESE scale provided support for the reliability and validity of the instrument in individuals with COPD. The ESE scale score shows a moderate positive correlation with functional exercise capacity and a negative correlation with health-related quality of life. In addition to a strong correlation with psychological status. In future research, the predictive power of the ESE scale in adherence to non-pharmacological treatment could be studied.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.